Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Medicina Oral, Patologia Oral Y Cirugia Bucal|October 31, 2006
Lepromatous leprosy: a review and case reportEduardo Chimenos Küstner, Montserrat Pascual Cruz, Cristina Pinol Dansis, et al.
Protein Engineering|May 11, 1999
Structure and function prediction of the Brucella abortus P39 protein by comparative modeling with marginal sequence similaritiesK de Fays, A Tibor, C Lambert, et al.
The Journal of Biological Chemistry|March 24, 2023
Structure and RAF family kinase isoform selectivity of type II RAF inhibitors tovorafenib and naporafenibEmre Tkacik, Kunhua Li, Gonzalo Gonzalez-Del Pino, et al.
NPJ Regenerative Medicine|February 17, 2018
Raman spectroscopic imaging for quantification of depth-dependent and local heterogeneities in native and engineered cartilageM B Albro, M S Bergholt, J P St-Pierre, et al.
Nature Communications|December 15, 2018
Virus-mediated export of chromosomal DNA in plantsMarco Catoni, Emanuela Noris, Anna Maria Vaira, et al.
Scientific Reports|October 7, 2021
Different roles of conserved tyrosine residues of the acylated domains in folding and activity of RTX toxinsAnna Lepesheva, Adriana Osickova, Jana Holubova, et al.
Nano Letters|March 31, 2021
Detergent-free Lipodisq Nanoparticles Facilitate High-Resolution Mass Spectrometry of Folded Integral Membrane ProteinsKin Kuan Hoi, Juan Francisco Bada Juarez, Peter J Judge, et al.
Frontiers in Cellular and Infection Microbiology|July 3, 2023
A conserved epitope in VAR2CSA is targeted by a cross-reactive antibody originating from <i>Plasmodium vivax</i> Duffy binding proteinUwa Iyamu, Daniel Ferrer Vinals, Bernard Tornyigah, et al.
Iscience|October 27, 2025
Adjuvants and MHCII modulate the immunogenicity of subdominant epitopes in <i>Plasmodium vivax</i> Duffy binding proteinDaniel Ferrer Vinals, Mohammad Rafiul Hoque, Opeyemi Ernest Oludada, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 22, 2026
Depemokimab reduces asthma exacerbations similarly to other biologics: systematic trial review and indirect treatment comparisonArnaud Bourdin, Ian D Pavord, Nicholas Ballew, et al.
Pageof 7